132 related articles for article (PubMed ID: 37231960)
1. International Newborn Screening Practices for the Early Detection of Congenital Adrenal Hyperplasia.
Conlon TA; Hawkes CP; Brady JJ; Loeber JG; Murphy N
Horm Res Paediatr; 2024; 97(2):113-125. PubMed ID: 37231960
[TBL] [Abstract][Full Text] [Related]
2. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
[TBL] [Abstract][Full Text] [Related]
3. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
Sarafoglou K; Banks K; Gaviglio A; Hietala A; McCann M; Thomas W
Pediatrics; 2012 Nov; 130(5):e1261-8. PubMed ID: 23071209
[TBL] [Abstract][Full Text] [Related]
4. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
[TBL] [Abstract][Full Text] [Related]
5. Can incorporating molecular testing improve the accuracy of newborn screening for congenital adrenal hyperplasia?
Sarafoglou K; Gaviglio A; Wolf C; Lorentz CP; Lteif A; Kyllo J; Radloff G; Detwiler Z; Cuthbert CD; Hodges JS; Grosse SD; Greene CN; Cordovado S
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38701341
[TBL] [Abstract][Full Text] [Related]
6. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
Clin Endocrinol (Oxf); 2021 Jun; 94(6):904-912. PubMed ID: 33471388
[TBL] [Abstract][Full Text] [Related]
7. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia.
Pode-Shakked N; Blau A; Pode-Shakked B; Tiosano D; Weintrob N; Eyal O; Zung A; Levy-Khademi F; Tenenbaum-Rakover Y; Zangen D; Gillis D; Pinhas-Hamiel O; Loewenthal N; de Vries L; Landau Z; Rachmiel M; Abu-Libdeh A; Eliakim A; Strich D; Koren I; German A; Sack J; Almashanu S
J Clin Endocrinol Metab; 2019 Aug; 104(8):3172-3180. PubMed ID: 30865229
[TBL] [Abstract][Full Text] [Related]
8. Severe adrenal insufficiency in six neonates with normal newborn screening for CAH.
Kurt I; Eser M; Kahveci A; Ucar A; Bulus D; Ozcabi B; Guran O; Karagozlu S; Ersoy A; Demir S; Geckinli B; Guran T
Clin Endocrinol (Oxf); 2024 May; ():. PubMed ID: 38796770
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.
de Hora MR; Heather NL; Webster DR; Albert BB; Hofman PL
Int J Neonatal Screen; 2022 Oct; 8(4):. PubMed ID: 36278626
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
[TBL] [Abstract][Full Text] [Related]
12. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
[TBL] [Abstract][Full Text] [Related]
13. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
14. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
15. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.
Lai F; Srinivasan S; Wiley V
Int J Neonatal Screen; 2020 Sep; 6(3):63. PubMed ID: 33117905
[TBL] [Abstract][Full Text] [Related]
17. Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States.
Speiser PW; Chawla R; Chen M; Diaz-Thomas A; Finlayson C; Rutter MM; Sandberg DE; Shimy K; Talib R; Cerise J; Vilain E; Délot EC
Int J Neonatal Screen; 2020 Jun; 6(2):. PubMed ID: 32832708
[TBL] [Abstract][Full Text] [Related]
18. Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.
de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
Int J Neonatal Screen; 2020 Mar; 6(1):6. PubMed ID: 33073005
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for congenital adrenal hyperplasia.
Therrell BL
Endocrinol Metab Clin North Am; 2001 Mar; 30(1):15-30. PubMed ID: 11344933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
